Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Wits Medical Consulting was a leading China-based CRO specializing in full-service clinical development for global and local pharmaceutical, biotechnology, and medical device companies, with expertise in Chinese regulatory processes and a strong track record in clinical trial execution. The company was known for its local knowledge, relationships with investigator sites, and advocacy of ICH GCP standards in China. It was acquired by ICON plc in 2012 to strengthen ICON’s presence and capabilities in China and the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Wits Medical Consulting.